Literature DB >> 9350776

Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States.

E K Korgenski1, J A Daly.   

Abstract

Forty-seven Bordetella pertussis isolates recovered from January 1985 to June 1997 at Primary Children's Medical Center were tested for erythromycin resistance. Agar dilution MICs were determined on Regan-Lowe agar. Forty-six isolates were found to be erythromycin susceptible (all MICs were less than or equal to 0.12 microg/ml). One isolate was found to be erythromycin resistant (MIC, 32 microg/ml). In addition, we compared Etest MIC results and disk diffusion zone diameter measurements, performed on commercially prepared Regan-Lowe agar, to the agar dilution MIC result. Etest MIC and/or disk diffusion testing on commercial Regan-Lowe agar appears to be an adequate method for erythromycin resistance screening of B. pertussis isolates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350776      PMCID: PMC230104          DOI: 10.1128/jcm.35.11.2989-2991.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  K A Gordon; J Fusco; D J Biedenbach; M A Pfaller; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.

Authors:  N K Fry; J Duncan; L Vaghji; R C George; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-03       Impact factor: 3.267

3.  Emergence of quinolone-resistant Bordetella pertussis in Japan.

Authors:  Masayuki Ohtsuka; Ken Kikuchi; Kenichiro Shimizu; Namiko Takahashi; Yuka Ono; Takashi Sasaki; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

Review 4.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

5.  Susceptibility testing of Bordetella pertussis.

Authors:  J E Hoppe
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.

Authors:  J M Bartkus; B A Juni; K Ehresmann; C A Miller; G N Sanden; P K Cassiday; M Saubolle; B Lee; J Long; A R Harrison; J M Besser
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Highlights of the 12th International Bordetella Symposium.

Authors:  Camille Locht; Nicholas H Carbonetti; James D Cherry; F Heath Damron; Kathryn M Edwards; Rachel Fernandez; Eric T Harvill; Daniela Hozbor; Kingston H G Mills; Maria Eugenia Rodriguez; Françoise Mascart
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.

Authors:  K E Wilson; P K Cassiday; T Popovic; G N Sanden
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Progress in the Diagnosis, Prevention, and Treatment of Pertussis.

Authors:  Flor M. Munoz; Wendy A. Keitel
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.